Two new classes of conopeptides inhibit the alpha1-adrenoceptor and noradrenaline transporter
about
A new level of conotoxin diversity, a non-native disulfide bond connectivity in alpha-conotoxin AuIB reduces structural definition but increases biological activityProtein Folding Determinants: Structural Features Determining Alternative Disulfide Pairing in α- and χ/λ-Conotoxins † , ‡Solution structure of an M-1 conotoxin with a novel disulfide linkageStructure of α-conotoxin BuIA: influences of disulfide connectivity on structural dynamicsConopeptide -TIA Defines a New Allosteric Site on the Extracellular Surface of the 1B-AdrenoceptorBmK-YA, an enkephalin-like peptide in scorpion venomDiversity of conotoxin gene superfamilies in the venomous snail, Conus victoriaeRole of voltage-gated calcium channels in ascending pain pathwaysTyrosine-rich conopeptides affect voltage-gated K+ channels.Conus peptides: biodiversity-based discovery and exogenomics.High-threshold mechanosensitive ion channels blocked by a novel conopeptide mediate pressure-evoked painIsolation and pharmacological characterization of AdTx1, a natural peptide displaying specific insurmountable antagonism of the alpha1A-adrenoceptor.Bioactive marine drugs and marine biomaterials for brain diseasesThe Venom Repertoire of Conus gloriamaris (Chemnitz, 1777), the Glory of the Sea.Diversity of conotoxin types from Conus californicus reflects a diversity of prey types and a novel evolutionary history.Identification of a novel snake peptide toxin displaying high affinity and antagonist behaviour for the α2-adrenoceptors.Deep venomics reveals the mechanism for expanded peptide diversity in cone snail venomOxidative folding and preparation of α-conotoxins for use in high-throughput structure-activity relationship studies.Conotoxin gene superfamilies.Spider-venom peptides as therapeutics.Cone snail venomics: from novel biology to novel therapeutics.Analgesic conotoxins: block and G protein-coupled receptor modulation of N-type (Ca(V) 2.2) calcium channels.Recent progress in alpha1-adrenergic receptor research.The solute carrier 6 family of transportersAncestral protein resurrection and engineering opportunities of the mamba aminergic toxinsA novel conotoxin, qc16a, with a unique cysteine framework and foldingHigh-throughput identification of novel conotoxins from the Chinese tubular cone snail (Conus betulinus) by multi-transcriptome sequencingDe novo sequencing and disulfide mapping of a bromotryptophan-containing conotoxin by Fourier transform ion cyclotron resonance mass spectrometry.Synthesis and solid-phase application of suitably protected gamma-hydroxyvaline building blocks.Targeting voltage-gated calcium channels for neuropathic pain management.Selective targeting of G-protein-coupled receptor subtypes with venom peptides.Therapeutic potential of conopeptides.Venom-based biotoxins as potential analgesics.Therapeutic conotoxins: a US patent literature survey.The role of defensive ecological interactions in the evolution of conotoxins.A Transcriptomic Survey of Ion Channel-Based Conotoxins in the Chinese Tubular Cone Snail (Conus betulinus).Pharmacokinetics and pharmacodynamics of intrathecally administered Xen2174, a synthetic conopeptide with norepinephrine reuptake inhibitor and analgesic properties.Influence of disulfide connectivity on structure and bioactivity of α-conotoxin TxIA.Novel alpha-conotoxins from Conus spurius and the alpha-conotoxin EI share high-affinity potentiation and low-affinity inhibition of nicotinic acetylcholine receptors.α-Conotoxin Vc1.1 inhibits human dorsal root ganglion neuroexcitability and mouse colonic nociception via GABAB receptors.
P2860
Q27639764-FD6F61ED-8C84-46AE-BFF0-2AA14D2998D5Q27643878-A35DCBA5-9A6F-4CC2-BDDD-13D7AD51C69AQ27644464-7F990FD8-58E9-4F7D-85FC-BF49521C6722Q27644513-A367D770-8AB1-4C90-B2FB-D3B4F2DE5D3DQ27675253-570B89FB-759C-4115-BD3E-3C3541C3649DQ28481178-B653711F-3AC4-4810-B857-7B0F924A7C72Q28539516-EDF04094-F9B9-4016-9731-44B6D2A42ADDQ30436560-9FA47816-4EE6-462B-9CF5-F3AAE42F4D29Q30487419-ADAF6537-B453-4845-A34D-BFEBB493312DQ33253748-83D36F98-F796-4DE5-B7E2-35723DCA6CCCQ33287466-629C7879-AE44-480A-A7D6-0AD959527712Q33673036-DF5369F2-EE35-4443-B7C6-7FEE1F1AF8D9Q33736687-5E61CAB5-3DCC-4D20-B625-74854538FDADQ33744170-21232DEA-BE9B-48F2-B419-2D65B7518C55Q33776402-4AF712A5-A7FA-4B3D-8817-C3FE407CBE6FQ34399307-8076C0CF-49CF-4795-A8A0-4842C314B77FQ34477088-DAB74474-436B-4504-ADD6-46D2C54E2514Q34495130-3802C433-42B9-4A9C-82E9-DD65C16C2D13Q34780602-B8B935CD-5F34-471F-996B-7A16C34B22E7Q35155666-DBBDBCD2-A6F9-48E1-B363-EB11AFCC5847Q35432836-E8F55CA8-C34B-4DC8-A067-725F2E99FD47Q36159142-A7085F6E-3E02-4EA9-A47C-2D5ABE4BFAAEQ36286458-44241B48-3F81-468D-8BB6-03068C4077F0Q36346899-0A7BEB25-C63A-4CBE-9F64-8887BA7E7738Q36391946-911931D0-F610-40FF-B673-5F2B60EF08EFQ36541551-7348676C-F41A-4DAC-A1E1-9258910BAC34Q36800495-C977F047-B70F-4A6B-B91D-9E5B981D68E7Q36841241-FF9BF564-3CBE-4A77-934B-AD6913C88C92Q36906634-59B623FE-872D-471B-927B-6B28F08263D4Q37605352-C3C18865-136C-4201-9542-A0F08F40E5BFQ37863750-7EC2DBF9-A725-4D04-A5F3-3DCCDB1C3544Q38026605-78EDDFE2-AC0C-4C7E-BAA9-8CD67D5FD0E4Q38252442-F01F96CA-1DB2-4533-B37A-6A0CC0A9C531Q38525254-5CB22A4E-552A-445E-8F99-AF170831B9C6Q38816124-3CE74090-9118-43FF-B165-8B39E54EBEEFQ39084750-4892E87A-2DA5-4DAC-B986-E81C2BC43C3CQ39093085-B3A55212-D90F-4D2D-B3CC-BB349DCA1C03Q39605620-306EB57D-A3A8-4B68-A0E7-F26C3466CAB3Q40106439-F5C386EC-ECC4-4DE8-A9C9-1B60303CC0D8Q41160258-D7FD9915-BA4B-42FB-A159-20E485450D8D
P2860
Two new classes of conopeptides inhibit the alpha1-adrenoceptor and noradrenaline transporter
description
2001 nî lūn-bûn
@nan
2001 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Two new classes of conopeptide ...... and noradrenaline transporter
@ast
Two new classes of conopeptide ...... and noradrenaline transporter
@en
Two new classes of conopeptide ...... and noradrenaline transporter
@nl
type
label
Two new classes of conopeptide ...... and noradrenaline transporter
@ast
Two new classes of conopeptide ...... and noradrenaline transporter
@en
Two new classes of conopeptide ...... and noradrenaline transporter
@nl
prefLabel
Two new classes of conopeptide ...... and noradrenaline transporter
@ast
Two new classes of conopeptide ...... and noradrenaline transporter
@en
Two new classes of conopeptide ...... and noradrenaline transporter
@nl
P2093
P2860
P3181
P356
P1433
P1476
Two new classes of conopeptide ...... and noradrenaline transporter
@en
P2093
Gehrmann J
Loughnan ML
P2860
P2888
P304
P3181
P356
10.1038/NN0901-902
P407
P577
2001-09-01T00:00:00Z
P5875
P6179
1020914274